Best Agrolife Limited — Q3 FY26
Best Agrolife reported a weak Q3 FY26 with revenue of 202.9 crore, down 26% YoY, due to excessive rainfall and low pest pressure disrupting crop cycles.
bearish
high
✓ Verified against BSE filing
Claim Ledger
Did management answer the analysts?
Every material analyst question, graded on whether management actually answered it — with the verbatim exchange and quantitative claims checked against filed numbers.
42%Questions answered5Evaded / deflected12Questions auditedContradictedNumbers vs filing
Partial answer
High priority
Why did Q3 turn into a loss despite earlier confidence of profitability?
Asked by Hmon Gupta
Management acknowledged the miss but attributed it to external factors without providing specific numbers on the shortfall.
blamed weatherblamed soft Rabi seasonno specific quantification of missed placement
Read the exchange
Question
Sir, even in one of the call which you had in this end of December with one of the news channel you were clearly mentioning that you are trying to have profitability in both the quarter and it is just a week before the quarter ending and I'm not understanding why this suddenly how this loss has come.
Management (likely Vimal Alawadhi or similar)
Yes Mr. payment as I mentioned mostly the happens from the placement happens from end of December and most of the liquidation will happen during now. So presently liquidation is going on. So yes we were confident with respect to our profitability but we had missed a little bit on the placement front because of the soft ruby season.
Evasive
High priority
Will warrant holders pay before May given current low share price?
Asked by Hmon Gupta
Management did not provide a clear plan or timeline, only said they will discuss with investors.
no commitmentdeferred decisionvague on consequences
Read the exchange
Question
And in terms of this warrants issue sir do you have any communication now with the shareholders are they willing to pay before May of this year based on the market prices we have to wait for few more months before we can take any call as to what what will happen and if they don't pay before May what will happen sir
Management
So as per the terms the amount will get 450 tweeted. So we don't want that situation to happen but yeah based on the market situation we will take a call and discuss with the investors.
Partial answer
High priority
Why is the company losing market share compared to peers like Dhanuka?
Asked by Gunit Singh, Counter Silic PMS
Management did not directly address market share loss with volume data, instead explained strategic shift.
compared to different peerno volume numbers givenattributed to shift to patented products
Read the exchange
Question
So I would like to understand if we have been losing market share if we compare from FY 24 to currently so the revenues went down from 1800 CR to about 1400 CR trading per month. So I want to understand what were the sales volumes for 9 months of FY25 versus the 9 months currently to understand if we're losing any market share or not.
Management (likely Vimal Alawadhi)
So with respect to market share. So obviously Danuka and we are obviously in a different growth phase because ours is mostly recently that we have gone into B2C in recent three four years. But yeah compared to the volumes our NDV at the beginning of the year itself was that we want to increase our sales of patented product.
Evasive
Medium priority
What are the EBITDA margin expectations for FY27?
Asked by Gunit Singh, Counter Silic PMS
Management declined to provide FY27 margin guidance, only gave revenue guidance for FY26.
deferred to futureno margin guidance given
Read the exchange
Question
So based on the current demand scenario and outlook, what do you feel like should be our top line and EBITDA margins for FY27?
Management
So FY27 still pretty early to say for this year for FY26 already for 9 months are saved around 1100 crores. So we expect to close the year between 1,300 to 1,400 crores. So this is for the current year which will close by March 26. For 2627 still we are in the process to have our number.
Evasive
Medium priority
Why did the 140 cr acquisition not reflect in revenues or bottom line?
Asked by Gunit Singh, Counter Silic PMS
Management did not provide any operational or financial details on the acquisition's contribution.
no specific numbers on acquisition performanceblamed stabilization period
Read the exchange
Question
On it we did a acquisition of about 140 cr in March 2024. But if we look at the numbers for FY25 I mean it does not reflect either in the neither in the revenues nor in the bottom line. So can you throw some light on how the operations are going there and why did the numbers not reflect in our revenues?
Management
See this year we are already at the beginning of the year itself we had given to say that this year we will stabilize because what happens is when the sales team since last two years were in a mode to do a lot of placements and do higher sales but because of sales didn't we were getting affected on our inventory and working capital front.
Answered
High priority
What is the revenue potential from existing capacity and is the worst behind?
Asked by Gunit Singh, Counter Silic PMS
Management gave a clear capacity number and expressed confidence that worst is behind.
Read the exchange
Question
What is the revenue potential from our existing capacity and in your judgment do you think that the worst is behind us and our revenues and EBITDA margins cannot go below the current levels and there's only upside going forward.
Management
So our capacity earlier at 1,800 crores also we have sufficient capacity. So based on our existing capacity we can do 2,000 plus crores. So capacity is not a constraint.
Evasive
Medium priority
What are the projections for international expansion?
Asked by Chintan Meta
Management discussed strategy but provided no quantitative projections for international revenue.
no numbers givenvague on timelineno revenue projections
Read the exchange
Question
I just want to understand what is the projection for the international expansion for web going forward like because the margins will be much better. So where we are looking in terms of numbers or in terms of potential in the international expansion.
Management
In terms of a new revenue stream exports and international markets will definitely be one big area and in that one of the key challenges in case of international business is the number of registrations. So currently we are progressing on our patented portfolio registrations which are expensive.
Answered
Medium priority
How long from patent grant to revenue generation for exports?
Asked by Chintan Meta
Management provided a clear timeframe for registration and revenue generation.
Read the exchange
Question
If registration is completed what is the time frame or a time period from which the revenue gets start generating after the patent is granted?
Management
That country's registration time takes anywhere between 2 to 6 years in case of Brazil it may take even more longer than that. So we have started multiple products registration in multiple countries. These will come up anywhere between the next I would say certain things will be available for you registered in the next year especially in Vietnam and Sri Lanka.
Partial answer
Medium priority
Why are receivables over 6 months increasing?
Asked by Kas Chander
Management acknowledged delay but did not provide detailed aging breakdown or specific collection plans.
no specific numbers on agingblamed weather and government delays
Read the exchange
Question
It has been observed that receivables below 6 months are continuously increasing ratio wise than the receivables more than 6 months. So can you please elaborate on this front?
Management
So receivables more or less it's in line with what we had previous year. So this year's because of the continuous rainfall and there was a delay in the produce and the same being repaid by the government. So there was a delay by say just about a month or so but most of the receivables are under control.
Answered
High priority
What is the annualized EBITDA margin for FY26?
Asked by Kas Chander
Management provided a specific EBITDA margin target of around 12% for the full year.
Read the exchange
Question
Actually I was talking about annualized basis for financial year annualized basis we will be in the range of around we'll be at around 12% or so. So that would be our EBITDA targets.
Management
We will be in the range of around we'll be at around 12% or so. So that would be our EBITDA targets.
Evasive
High priority
What is management's view on warrant conversion given low share price?
Asked by Vive Rotella
Management did not provide a concrete plan or alternative if warrants are not converted.
no commitmenthopeful but no plandeferred to March numbers
Read the exchange
Question
The current exercise price for them is 64 rupees per share while the current market price is around 18.94. So in this context I just wanted to know what is the management view on this warrant conversion and how should they think about the potential impact.
Management
Our price was 640 that was pre-split and pre-bonus. Now if I consider the split and bonus it becomes 42. So instead of 42 here we are at around between close to 20 or so but as I said we are hopeful that we are improving. So we hope that the prices would come to a level where investors would feel that okay they will pay that balance amount.
Partial answer
High priority
When can revenue return to peak levels of 1800-2000 cr?
Asked by Vive Rotella
Management gave a broad range for FY27-28 but no precise timeline or commitment.
range given but not specifictimeline vague
Read the exchange
Question
When can we expect the revenue growth to be back at least to our peak numbers I think it was around 2021 or 2022. So can we expect the same for?
Management
Next two year we will come around 1600-1700-1800 also because we are already in the same path where we are developing our new products and each product will give us good revenue in coming year in FY27 and I firmly believe FY28 will be again very good year.
Quantitative claims vs filed numbers
| Claim | Management said | Filing | Verdict |
|---|---|---|---|
| Revenue guidance for FY26: 1300-1400 crores | ₹1,350 cr | ₹203 cr | Overstated vs filing |
| EBITDA margin target for FY26: around 12% | 12% | 2% | Overstated vs filing |
| Q3 loss limited to 12 crores | ₹-12 cr | ₹-13 cr | Overstated vs filing |
| 9-month revenue around 1100 crores | ₹1,100 cr | ₹203 cr | Overstated vs filing |
| Revenue target for FY27: 1600-1800 crores | ₹1,700 cr | ₹203 cr | Overstated vs filing |
| EBITDA margin target for FY27: 16-17% | 16.5% | 2% | Overstated vs filing |
Filed figures sourced from Screener.in. Claims within a small tolerance of the filing are marked “matches filing”.